Interventional studies assessing the impact of uromodulin levels on the antihypertensive effect of NKCC2/NCC blockade and/or salt restriction, as well as large population studies investigating the value of adding UMOD genotyping in diagnostic and/or therapeutic algorithms of hypertension, are needed. This evidence concerns the gene SLC12A3 and Hypertension.